Corporations aren't looking just for app developers. Johnson & Johnson and GlaxoSmithKline each put $50 million last year into a $200 million venture fund to support early-stage biotech firms. In addition, J&J is creating four innovation centers--in Boston, London, Shanghai, and San Francisco--to fund early-stage life-science research and help push products forward faster. Roughly 70 J&J scientists and research and development executives at the centers will mentor entrepreneurs and provide industry introductions. The company also created a biotech incubator at its Janssen Labs in San Diego, where early-stage companies can rent office and lab space without having to commit any of their research to J&J.
JANSSEN LABS | A capital efficient, flexible model for companies pursuing healthcare innovations
In The News
Lab incubates life-science startups
For a startup company, being located in the right environment can be nearly as important as having the right people and technology.Telmedx, a San Diego-based telemedicine company, says it found that environment at Janssen Labs, the life-science business incubator owned by Janssen Research & Development.And Janssen is betting that more firms like Telmedx will share that impression.
Big pharma turns to incubators, crowd sourcing for new products
Big innovation requires big new thinking, and big pharma knows that simply throwing big billions of dollars at a problem isn’t efficient and effective. How they’re shaking things up was the topic of a recent seminar sponsored by Prescience International and Janssen Labs at Janssen’s San Diego incubator facility.
J&J: 'Innovation center' could include life sciences incubator
Johnson & Johnson's new "innovation center" could be a clearinghouse for new drug deals and investments by the drug and device powerhouse or more involved incubator for new companies, a J&J research executive said Tuesday.
A decision on where to house the Bay Area center -- one of four regional J&J sites globally -- will come soon, said Diego Miralles, the head of J&J's Janssen Healthcare Innovation unit, West Coast Research Center and Janssen Labs.
"Further south takes you closer to the venture community; north in Mission Bay or South San Francisco is more biotech; and even further south is more devices," Miralles said. "We're trying to figure out exactly where (the center will go)."
Biotech Innovation, Risks, Raising Capital
Yesterday, RE:INVENTION attended Prescience International's "Catalyzing Life Science Startups" event at San Diego's Janssen Labs. Moderator Diego Miralles, Head of the Janssen R&D West Coast Research Center and Janssen Healthcare Innovation...
Finance 101 as VCs Clue in Startups at J&J’s San Diego Incubator
Janssen Research and Development, a Johnson & Johnson company, recently took another step in supporting life science startups in San Diego by bringing together a panel of venture capitalists to speak with fledgling companies about what it takes to win investment...
Janssen Labs Featured in ennTV YouTube Video
In this innovation episode of ennTV, see how Johnson & Johnson is supporting startup life science innovation at Janssen Labs in La-Jolla, California. Janssen Research & Development provides emerging healthcare companies big company advantages in a no-strings-attached model....
San Diego Stands as a Top U.S. Bioregion
When French molecular biologist Patrick Merel, Ph.D., decided to establish a biotech company to develop and market a smartphone software program to store and display an individual’s DNA sequence...
